Vitura Health Ltd (ASX: VIT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Vitura Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $77.74 million
P/E Ratio 8.13
Dividend Yield 7.41%
Shares Outstanding 575.87 million
Earnings per share 0.024
Dividend per share 0.01
Year To Date Return -47.06%
Earnings Yield 12.30%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Vitura Health Ltd (ASX: VIT)
    Latest News

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    How did ASX cannabis shares perform in FY22?

    Here's a look at the sector's performance in the financial year just gone.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    Remember when ASX cannabis shares were smoking hot? Where are they now?

    Newly legalised recreational and medicinal marijuana markets aren't getting the media hype they once did.

    Read more »

    Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
    Cannabis Shares

    How have ASX cannabis shares been performing so far in 2022?

    The sector has held its own during volatile times.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Cannabis Shares

    This little-known ASX cannabis share has quietly gained 26% in a month to trade at all-time highs

    Why is this ASX cannabis share having such a stellar month?

    Read more »

    Five healthcare workers standing together and smiling.
    Healthcare Shares

    2 ASX healthcare shares bucking the trend to hit new highs on Friday

    These healthcare shares are on form on Friday

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    These were the best-performing ASX cannabis shares in 2021

    Despite a mixed bag for cannabis shares, some ended the year on a high

    Read more »

    a medical person in white coat, gloves and protective eyewear uses tools and a test tube to put cannabis buds into the tube for research purposes.
    Share Gainers

    Why is the Cronos (ASX:CAU) share price soaring 45% today?

    We check the latest on the ASX medical cannabis company.

    Read more »

    A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
    Cannabis Shares

    What's the outlook for ASX Cannabis shares in 2022?

    December has been a tricky month for ASX cannabis shares.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    These were the top performing ASX cannabis shares in November

    It was a tough month for ASX cannabis shares but we've identified 3 diamonds in the rough.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2023 $0.0100 100.00% Final 28 Sep 2023
    16 Sep 2022 $0.0100 100.00% Final 11 Oct 2022

    VIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Vitura Health Ltd

    Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has three business segments namely, the Medical segment, which involves the sale of medicinal cannabis products; the Clinics segment, which involves the operation of medicinal cannabis clinics; and the Consumer segment, which involves the sale of consumer (non-medical) products in Australia and previously in Asia. The company generates the majority of its revenue from the Medical segment. Geographically the company generates the majority of its revenue from Australia.

    VIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Mar 2024 $0.14 $-0.01 -7.14% 721,541 $0.14 $0.14 $0.13
    29 Feb 2024 $0.14 $-0.03 -18.18% 1,752,370 $0.17 $0.17 $0.14
    28 Feb 2024 $0.17 $0.01 6.45% 512,802 $0.17 $0.17 $0.16
    27 Feb 2024 $0.16 $-0.01 -6.06% 958,901 $0.16 $0.17 $0.16
    26 Feb 2024 $0.17 $-0.06 -26.67% 3,217,218 $0.21 $0.21 $0.15
    23 Feb 2024 $0.23 $-0.02 -8.33% 336,447 $0.24 $0.24 $0.23
    22 Feb 2024 $0.24 $-0.01 -4.00% 263,977 $0.25 $0.25 $0.24
    21 Feb 2024 $0.25 $0.00 0.00% 5,331 $0.24 $0.25 $0.24
    20 Feb 2024 $0.25 $0.01 4.17% 101,389 $0.25 $0.25 $0.25
    19 Feb 2024 $0.24 $-0.02 -7.84% 267,405 $0.26 $0.26 $0.24
    16 Feb 2024 $0.26 $0.02 8.33% 352,604 $0.25 $0.26 $0.25
    15 Feb 2024 $0.24 $0.00 0.00% 39,057 $0.24 $0.25 $0.24
    14 Feb 2024 $0.24 $0.00 0.00% 106,689 $0.24 $0.25 $0.24
    13 Feb 2024 $0.24 $-0.01 -4.08% 74,808 $0.24 $0.25 $0.24
    12 Feb 2024 $0.25 $0.01 4.17% 28,143 $0.25 $0.25 $0.25
    09 Feb 2024 $0.24 $0.01 4.26% 8,650 $0.24 $0.24 $0.24
    08 Feb 2024 $0.24 $-0.02 -8.00% 69,175 $0.25 $0.25 $0.24
    07 Feb 2024 $0.25 $0.01 4.17% 70,544 $0.24 $0.25 $0.24
    06 Feb 2024 $0.24 $-0.01 -4.00% 92,287 $0.25 $0.25 $0.24
    05 Feb 2024 $0.25 $0.00 0.00% 501,723 $0.26 $0.26 $0.25
    02 Feb 2024 $0.25 $0.00 0.00% 52,146 $0.26 $0.26 $0.25
    01 Feb 2024 $0.25 $0.01 4.08% 79,859 $0.24 $0.25 $0.24

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Dec 2023 Rodney Cocks Issued 1,241,808 $335,288
    Issue of securities.
    30 Aug 2023 Guy Headley Expiry 1,500,000 $577,500
    Options expired.
    25 Aug 2023 Guy Headley Exercise 1,500,000 $405,000
    Exercise of options.
    25 Aug 2023 Guy Headley Buy 1,500,000 $405,000
    Exercise of options.
    21 Jul 2023 Guy Headley Expiry 1,500,000 $750,000
    Options expired. As per announcement on 28-07-2023
    19 May 2023 Guy Headley Sell 18,750,000 $6,000,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Rodney Damon Cocks Chief Executive OfficerExecutive Director Sep 2018
    Mr Cocks is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co founded. Prior to joining Vitura, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
    Mr Guy Rothwell Headley Non-Executive Director Dec 2021
    Mr Headley has operated in the Australian Medicinal Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last seven years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chairman of the Emerging Therapeutics Association of Australia.
    Ms Marcia Ani Matekino Walker Non-Executive Director Dec 2021
    Ms Walker brings experience in Medical Governance and formerly served on the board of the New Zealand Medical Association and as a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association.
    Ms Jenelle Lee Frewen Non-Executive Director Sep 2022
    Ms Frewen is an accomplished government strategist and adviser with more than two decades' experience spanning complex policy development and implementation in regulated industries. She has led several federal and state political campaigns, and advised a range of business clients on public affairs and regulatory policy. She has experience working at all three levels of government in Australia and in new areas of policy-making in technology, broadband and cyber safety. Jenelle also spent time in her early career working as a communications and media adviser in the private sector in Australia, and was a senior aide in municipal government in the United States. She is currently Principal Consultant with the Canberra-based advisory firm, Precision Public Affairs.
    Mr Robert Iervasi Non-Executive ChairmanNon-Executive Director Feb 2024
    Mr Iervasi is a Chair, Board Director, former Group CEO, CFO and General Counsel. Most recently he was the Group CEO of Asahi Beverages, which owns Carlton and United Breweries (CUB). Currently, Mr Iervasi serves as Chair at Luv a Duck and Charters Paper, and is a Non Executive Director at SPC Global. With a background in both corporate governance and consumer products, Mr Iervasi is experience as a CFO, General Counsel and CEO through the various executive and Board roles he has held, including Asahi Beverages, HS Fresh Foods Group, Allpress Expresso and Circular Plastics Australia.
    Mr Thomas Godfrey Howitt Chief Financial OfficerCompany Secretary Aug 2020
    -
    Guy R. Headley Chief Commercial Officer
    -
    Thomas Godfrey Howitt Chief Financial OfficerCompany Secretary
    -
    Jessimine C.K. Jansen Chief Operating Officer
    -
    Ryan J. Tattle Chief Revenue Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Elizabeth Sarah Jansen <Stanford Investment Trust> 118,957,765 21.30%
    Guy Rothwell Headley 109,048,772 19.53%
    Cronos Global Holdings Inc. 55,176,065 9.88%
    Matua Hasyo Charlie Jansen <Whanau Family Trust> 47,738,638 8.55%
    HSBC Custody Nominees (Australia) Limited 22,470,003 4.02%
    NewSouthern Investment Holdings 1 Pty. Ltd.<NewSouthern Investment Trust 1> 21,000,000 3.76%
    NewSouthern Investment Holdings A Pty. Ltd. 20,000,000 3.58%
    Stone Group Pty. Ltd. <Stone Children A/C> 19,950,243 3.57%
    Ashanna Pty. Ltd. 10,766,897 1.93%
    Hektares SG Holdings Pte. Ltd. 6,665,216 1.19%
    UBS Nominees Pty. Ltd. 5,974,530 1.07%
    Citicorp Nominees Pty. Limited 4,958,589 0.89%
    Jessimine Jansen 4,653,379 0.83%
    BNP Paribas Nominees Pty. Ltd. <IB AU Noms Retail Client DRP> 4,266,870 0.76%
    Daniel Francis Birch <BES A/C> 3,798,013 0.68%
    Ryan Tattle 3,451,189 0.62%
    Arawhero Pty. Ltd. <Arawhero Super Fund A/C> 2,975,604 0.53%
    Kanmed Investments Pty. Ltd. 2,368,718 0.42%
    Marienburg Pty. Ltd. <Robinson Family A/C> 1,779,160 0.32%
    BG & Dewar Pty. Ltd. 1,373,500 0.25%

    Profile

    since

    Note